Cargando…

Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats

INTRODUCTION: Mesenchymal stromal cells (MSCs) have particular properties that are of interest in organ transplantation, including the expansion of regulatory T cells (Tregs), a key factor in transplant tolerance induction. However, the most effective immunosuppressive drug to associate with MSCs ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandermeulen, Morgan, Erpicum, Pauline, Bletard, Noella, Poma, Laurence, Jouret, François, Detry, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226583/
https://www.ncbi.nlm.nih.gov/pubmed/35757737
http://dx.doi.org/10.3389/fimmu.2022.877953
_version_ 1784733936781361152
author Vandermeulen, Morgan
Erpicum, Pauline
Bletard, Noella
Poma, Laurence
Jouret, François
Detry, Olivier
author_facet Vandermeulen, Morgan
Erpicum, Pauline
Bletard, Noella
Poma, Laurence
Jouret, François
Detry, Olivier
author_sort Vandermeulen, Morgan
collection PubMed
description INTRODUCTION: Mesenchymal stromal cells (MSCs) have particular properties that are of interest in organ transplantation, including the expansion of regulatory T cells (Tregs), a key factor in transplant tolerance induction. However, the most effective immunosuppressive drug to associate with MSCs has yet to be defined. Additionally, the impact of the association of everolimus with MSCs on Treg expansion, and on the induction of liver graft tolerance, has never been studied. The aim of this study was to evaluate the effects of MSCs in combination, or not, with everolimus on Treg expansion and in a model of rejection after liver transplantation (LT) in the rat. METHODS: Firstly, 24 Lewis rats were assigned to 4 groups (n=6 in each group) receiving intravenous MSCs or saline injection at day (D)9 with/without subcutaneous everolimus from D0 to D14. Analysis of circulating Tregs was performed at D0, D14 and D28. In a second set of experiment, 30 Lewis rats were randomized in 3 groups 48hours after LT with a Dark Agouti rat liver: everolimus (subcutaneous for 14 days), MSCs (intravenous injection at post-operative day 2 and 9), or both everolimus and MSCs. Rejection of the liver graft was assessed by liver tests, histology and survival. RESULTS: Individually, MSC infusion and everolimus promoted Treg expansion in rats, and everolimus had no negative impact on Treg expansion in combination with MSCs. However, in the LT model, injections of MSCs two and nine days following LT were not effective at preventing acute rejection, and the combination of MSCs with everolimus failed to show any synergistic effect when compared to everolimus alone. CONCLUSION: Everolimus may be used in association with MSCs. However, in our model of LT in the rat, post-transplant MSC injections did not prevent acute rejection, and the association of MSCs with everolimus did not show any synergistic effect.
format Online
Article
Text
id pubmed-9226583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92265832022-06-25 Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats Vandermeulen, Morgan Erpicum, Pauline Bletard, Noella Poma, Laurence Jouret, François Detry, Olivier Front Immunol Immunology INTRODUCTION: Mesenchymal stromal cells (MSCs) have particular properties that are of interest in organ transplantation, including the expansion of regulatory T cells (Tregs), a key factor in transplant tolerance induction. However, the most effective immunosuppressive drug to associate with MSCs has yet to be defined. Additionally, the impact of the association of everolimus with MSCs on Treg expansion, and on the induction of liver graft tolerance, has never been studied. The aim of this study was to evaluate the effects of MSCs in combination, or not, with everolimus on Treg expansion and in a model of rejection after liver transplantation (LT) in the rat. METHODS: Firstly, 24 Lewis rats were assigned to 4 groups (n=6 in each group) receiving intravenous MSCs or saline injection at day (D)9 with/without subcutaneous everolimus from D0 to D14. Analysis of circulating Tregs was performed at D0, D14 and D28. In a second set of experiment, 30 Lewis rats were randomized in 3 groups 48hours after LT with a Dark Agouti rat liver: everolimus (subcutaneous for 14 days), MSCs (intravenous injection at post-operative day 2 and 9), or both everolimus and MSCs. Rejection of the liver graft was assessed by liver tests, histology and survival. RESULTS: Individually, MSC infusion and everolimus promoted Treg expansion in rats, and everolimus had no negative impact on Treg expansion in combination with MSCs. However, in the LT model, injections of MSCs two and nine days following LT were not effective at preventing acute rejection, and the combination of MSCs with everolimus failed to show any synergistic effect when compared to everolimus alone. CONCLUSION: Everolimus may be used in association with MSCs. However, in our model of LT in the rat, post-transplant MSC injections did not prevent acute rejection, and the association of MSCs with everolimus did not show any synergistic effect. Frontiers Media S.A. 2022-06-10 /pmc/articles/PMC9226583/ /pubmed/35757737 http://dx.doi.org/10.3389/fimmu.2022.877953 Text en Copyright © 2022 Vandermeulen, Erpicum, Bletard, Poma, Jouret and Detry https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Vandermeulen, Morgan
Erpicum, Pauline
Bletard, Noella
Poma, Laurence
Jouret, François
Detry, Olivier
Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title_full Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title_fullStr Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title_full_unstemmed Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title_short Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
title_sort effect of the combination of everolimus and mesenchymal stromal cells on regulatory t cells levels and in a liver transplant rejection model in rats
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226583/
https://www.ncbi.nlm.nih.gov/pubmed/35757737
http://dx.doi.org/10.3389/fimmu.2022.877953
work_keys_str_mv AT vandermeulenmorgan effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats
AT erpicumpauline effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats
AT bletardnoella effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats
AT pomalaurence effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats
AT jouretfrancois effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats
AT detryolivier effectofthecombinationofeverolimusandmesenchymalstromalcellsonregulatorytcellslevelsandinalivertransplantrejectionmodelinrats